Harmony Gold Mining Company Limited (JSE:HAR)

CTI BioPharma Ratios and Metrics

Market cap in millions ZAR. Fiscal year is July - June.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 12, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Market Capitalization	169,458	104,180	48,978	32,038	32,178	43,339
Market Cap Growth	26.01%	112.71%	52.87%	-0.43%	-25.75%	152.97%
Enterprise Value	162,699	104,539	53,778	32,976	32,929	47,760
Last Close Price	272.36	165.64	76.74	50.10	50.32	67.38
PE Ratio	16.34	12.13	10.16	-	6.33	-
Forward PE	8.37	7.40	5.62	6.21	4.80	5.93
PS Ratio	2.53	1.70	0.99	0.75	0.77	1.48
PB Ratio	3.68	2.54	1.40	1.06	1.03	1.85
P/TBV Ratio	3.70	2.56	1.41	1.07	1.05	1.90
P/FCF Ratio	17.83	14.37	21.22	45.12	7.97	38.94
P/OCF Ratio	8.99	6.66	4.92	4.63	3.51	9.18
PEG Ratio	0.19	0.10	0.10	0.10	0.10	0.10
EV/Sales Ratio	2.42	1.70	1.09	0.77	0.79	1.63
EV/EBITDA Ratio	7.42	5.57	4.85	4.40	3.01	12.03
EV/EBIT Ratio	9.43	7.27	6.80	8.64	4.67	103.15
EV/FCF Ratio	17.12	14.42	23.30	46.45	8.16	42.91
Debt / Equity Ratio	0.05	0.06	0.18	0.12	0.11	0.34
Debt / EBITDA Ratio	0.11	0.12	0.55	0.49	0.31	1.98
Debt / FCF Ratio	0.26	0.32	2.70	5.14	0.83	7.06
Asset Turnover	1.04	1.04	0.95	0.89	0.89	0.72
Inventory Turnover	12.45	11.56	11.67	12.54	12.15	10.19
Quick Ratio	1.43	0.94	0.74	0.83	0.81	1.00
Current Ratio	1.84	1.56	1.26	1.51	1.54	1.35
Return on Equity (ROE)	24.78%	22.91%	15.02%	-3.30%	18.77%	-3.70%
Return on Assets (ROA)	16.66%	15.27%	9.50%	4.99%	9.43%	0.71%
Return on Capital (ROIC)	23.28%	21.31%	13.20%	6.98%	13.40%	0.97%
Return on Capital Employed (ROCE)	28.80%	27.10%	15.70%	9.10%	16.30%	1.20%
Earnings Yield	6.21%	8.24%	9.84%	-3.28%	15.81%	-2.03%
FCF Yield	5.61%	6.96%	4.71%	2.22%	12.55%	2.57%
Dividend Yield	1.17%	1.46%	0.98%	1.24%	2.72%	-
Payout Ratio	14.50%	16.23%	2.82%	-	13.31%	-
Buyback Yield / Dilution	-1.73%	-1.49%	-0.95%	0.29%	-15.14%	-2.20%
Total Shareholder Return	-0.60%	-0.03%	0.02%	1.52%	-12.42%	-2.20%

Updated Mar 4, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.